Yahoo Finance

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

HARRISON, N.Y., March 31, 2026 (GLOBE NEWSWIRE)-- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company and pioneer in venous sinus stenosis treatment, today announced U.S. Food and ...
Yahoo Finance

Serenity Medical Announces Clinical Publication of First Prospective Multicenter Trial of the River™ Stent, a Novel Venous Sinus Stent for Treating Idiopathic Intracranial ...

HARRISON, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Serenity Medical, a NeuroTechnology Investors (NTI) portfolio company dedicated to the treatment of venous sinus stenosis, today announced the ...
manilatimes

Serenity Medical Receives U.S. FDA HDE Approval of the River™ Stent - the First Venous Stent Approved for Severe, Refractory Idiopathic Intracranial Hypertension (IIH)

Landmark regulatory milestone makes the River stent available for adults with severe IIH - a debilitating, historically undertreated condition - who have failed medical therapy Serenity Medical ...